Collection and Processing: UVA Illumination
Collection & Processing: UVA Illumination to Activate Amotosalen.
The container of platelets or plasma containing amotosalen is inserted into a microprocessor-controlled benchtop illuminator, which exposes the unit to UVA light for approximately 3 to 6 minutes. The illumination step activates amotosalen to crosslink the nucleic acids of susceptible pathogens and leukocytes which may be present — preventing their replication.
 |
Platelets or plasma are illuminated with UVA light. The illuminator can process either one or two units simultaneously.The illumination containers are agitated during illumination to ensure that the entire product receives the correct light dose. An LCD screen and easy-to-use software provide feedback for each step of the illumination process, and a bar code scanner facilitates data entry. |
Implementation and Use page 4 of 7 
©
Cerus Corporation. All Rights Reserved.
Use of the INTERCEPT Blood System in the United States is limited by Federal law to investigational use. If you are a resident of the U.S., please click here.
The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located. The INTERCEPT Blood System is CE marked for use with platelets and plasma.
Website design by NetPilot Web Solutions
Use of the INTERCEPT Blood System in the United States is limited by Federal law to investigational use. If you are a resident of the U.S., please click here.
The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located. The INTERCEPT Blood System is CE marked for use with platelets and plasma.
Website design by NetPilot Web Solutions